Picard Medical Device Sustains Patient 119 Days in Second Artificial Heart Bridge at UCSF
Picard Medical’s SynCardia Total Artificial Heart sustained a male patient in his twenties for 119 days before a successful heart transplant on March 14, 2026 at UCSF Health. This case represents the second of five planned total artificial heart bridges at UCSF, underscoring growing clinical adoption.
1. Second Successful Bridge to Transplant
A male patient in his twenties with advanced biventricular heart failure received the SynCardia Total Artificial Heart on November 15, 2025. After 119 days of full circulatory support, the device was explanted and the patient underwent a successful heart transplant on March 14, 2026 at UCSF Health.
2. UCSF Health Mechanical Support Program
This marks the second of five patients at UCSF bridged to transplant with the SynCardia system, following another successful redo sternotomy and explant procedure. The collaboration underscores UCSF’s growing experience and commitment to mechanical circulatory support for end-stage heart failure patients.
3. Implications for Picard Medical
The milestone highlights clinical validation of the SynCardia Total Artificial Heart and may accelerate adoption at leading transplant centers. Increased use in bridge-to-transplant therapies could boost Picard Medical’s implant volumes and revenue trajectory over the coming quarters.